Manganese
Pronunciation
(MAN ga nees)
Synonyms
Manganese Chloride; Manganese Sulfate
Generic Available
Yes
Use
Trace element added to total parenteral nutrition (TPN) solution to prevent manganese deficiency; orally as a dietary supplement
Pregnancy Risk Factor
C
Lactation
Enters breast milk/compatible
Contraindications
High manganese levels; severe liver dysfunction or cholestasis (conjugated bilirubin >2 mg/dL) due to reduced biliary excretion
Warnings/Precautions
Manganese chloride solution for injection contains aluminum; use caution with impaired renal function and in premature infants. Use caution with hepatic impairment.
Overdosage/Toxicology
Acute poisoning due to ingestion of manganese or manganese salts is rare (poor oral absorption). Manganese chloride solution for injection contains aluminum; aluminum doses >4-5 mcg/kg/day are associated with toxicity in patients with renal impairment and in premature neonates. The main symptoms of chronic poisoning, either from injection or usually inhalation of manganese dust or fumes, include extrapyramidal symptoms that can lead to progressive deterioration in the central nervous system.
Stability
Solution for injection: Store at controlled room temperature of 15°C to 30°C (59°F to 86°F); compatible with electrolytes usually present in amino acid/dextrose solution used for TPN solutions.
Mechanism of Action
Cofactor in many enzyme systems, stimulates synthesis of cholesterol and fatty acids in liver, and influences mucopolysaccharide synthesis
Pharmacodynamics/Kinetics
Absorption: Oral: Poor (3% to 4%)
Distribution: Concentrated in mitochondria of pituitary gland, pancreas, liver, kidney, and bone
Excretion: Bile (primarily); urine (negligible)
Dosage
Oral: Adequate intake:
0-6 months: 0.003 mg/day
7-12 months: 0.6 mg/day
1-3 years: 1.2 mg/day
4-8 years: 1.5 mg/day
9 years to Adults, Male: 1.9-2.3 mg/day
9 years to Adults, Female: 1.6-1.8 mg/day
Pregnancy: 2 mg/day
Lactation: 2.6 mg/day
I.V.:
Children: 2-10 mcg/kg/day usually administered in TPN solutions
Note:
Use caution in premature neonates; manganese chloride solution for injection contains aluminum
Adults: 150-800 mcg/day usually administered in TPN solutions
Dosage adjustment in renal impairment:
Use caution; manganese chloride solution for injection contains aluminum
Dosage adjustment in hepatic impairment:
Use caution; dose may need to be decreased or withheld
Administration
Solution for injection: Do not administer I.M. or by direct I.V. injection; acidic pH of the solution may cause tissue irritations and it is hypotonic
Monitoring Parameters
Periodic manganese plasma level
Reference Range
Plasma: 0.6-2 ng/mL
Dental Health: Effects on Dental Treatment
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions
No information available to require special precautions
Dosage Forms
Injection, solution, as chloride [preservative free]: 0.1 mg/mL (10 mL) [contains aluminum
100 mcg/mL]
Injection, solution, as sulfate: 0.1 mg/mL (10 mL)
Tablet, elemental: 50 mg, 100 mg
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program
is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s
editorial process
. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.